In the latest quarter, 6 analysts provided ratings for Boston Scientific (NYSE:BSX), showcasing a mix of bullish and bearish perspectives. The following table encapsulates their recent ratings, ...
With a market cap of $138.8 billion, Boston Scientific Corporation (BSX)is a global medical device company that develops, manufactures, and markets innovative technologies across interventional ...
In recent days, Boston Scientific has drawn upbeat commentary from Wall Street, with analysts citing strong demand across electrophysiology and structural heart, ongoing trials such as its Global ...